Do analysts rate BHC or APHA?

Given Aphria's higher possible upside, analysts plainly believe Aphria is more favorable than Bausch Health Companies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bausch Health Companies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Aphria 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher valuation & earnings, BHC or APHA?

Bausch Health Companies has higher revenue and earnings than Aphria. Bausch Health Companies is trading at a lower price-to-earnings ratio than Aphria, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Bausch Health Companies C$10.53B 0.25 -C$125.65M -C$3.24 N/A Aphria C$611.06M 0.00 -C$637.39M -C$2.01 N/A

Do analysts prefer BHC or PBH?

Premium Brands has a consensus target price of C$118.62, indicating a potential upside of 34.61%. Given Premium Brands' stronger consensus rating and higher possible upside, analysts clearly believe Premium Brands is more favorable than Bausch Health Companies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bausch Health Companies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Premium Brands 0 Sell rating(s) 1 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.92

Do analysts prefer AUP or BHC?

Given Aurinia Pharmaceuticals' higher possible upside, equities analysts clearly believe Aurinia Pharmaceuticals is more favorable than Bausch Health Companies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurinia Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Bausch Health Companies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts prefer SLS or BHC?

Solaris Resources currently has a consensus price target of C$19.50, suggesting a potential upside of 48.85%. Given Solaris Resources' stronger consensus rating and higher probable upside, equities analysts plainly believe Solaris Resources is more favorable than Bausch Health Companies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solaris Resources 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Bausch Health Companies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts recommend CARA or BHC?

Given Cara Operations' higher probable upside, equities analysts plainly believe Cara Operations is more favorable than Bausch Health Companies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cara Operations 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Bausch Health Companies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has preferable earnings and valuation, CARA or BHC?

Cara Operations has higher earnings, but lower revenue than Bausch Health Companies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cara Operations N/A N/A N/A N/A N/A Bausch Health Companies C$10.53B 0.25 -C$125.65M -C$3.24 N/A

Bausch Health Companies (BHC) Competitors

C$7.09 0.00 (0.00%)

As of 06/12/2026 04:00 PM Eastern

Compare

BHC vs. APHA, PBH, AUP, SLS, and CARA

Should you buy Bausch Health Companies stock or one of its competitors? MarketBeat compares Bausch Health Companies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Bausch Health Companies include Aphria (APHA), Premium Brands (PBH), Aurinia Pharmaceuticals (AUP), Solaris Resources (SLS), and Cara Operations (CARA). These companies are all part of the "pharmaceutical products" industry.

How does Bausch Health Companies compare to Aphria?

Bausch Health Companies (TSE:BHC) and Aphria (TSE:APHA) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and dividends.

In the previous week, Bausch Health Companies' average media sentiment score of 0.00 equaled Aphria'saverage media sentiment score.

Company	Overall Sentiment
Bausch Health Companies	Neutral
Aphria	Neutral

Bausch Health Companies has higher revenue and earnings than Aphria. Bausch Health Companies is trading at a lower price-to-earnings ratio than Aphria, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bausch Health Companies	C$10.53B	0.25	-C$125.65M	-C$3.24	N/A
Aphria	C$611.06M	0.00	-C$637.39M	-C$2.01	N/A

Aphria has a net margin of 0.00% compared to Bausch Health Companies' net margin of -13.54%. Bausch Health Companies' return on equity of 120.43% beat Aphria's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bausch Health Companies	-13.54%	120.43%	4.16%
Aphria	N/A	N/A	N/A

Given Aphria's higher possible upside, analysts plainly believe Aphria is more favorable than Bausch Health Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bausch Health Companies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Aphria	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

11.0% of Bausch Health Companies shares are owned by institutional investors. 11.3% of Bausch Health Companies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Bausch Health Companies beats Aphria on 8 of the 11 factors compared between the two stocks.

How does Bausch Health Companies compare to Premium Brands?

Bausch Health Companies (TSE:BHC) and Premium Brands (TSE:PBH) are both mid-cap pharmaceutical products companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends.

Premium Brands has a net margin of 0.52% compared to Bausch Health Companies' net margin of -13.54%. Bausch Health Companies' return on equity of 120.43% beat Premium Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bausch Health Companies	-13.54%	120.43%	4.16%
Premium Brands	0.52%	2.21%	3.61%

Premium Brands has a consensus target price of C$118.62, indicating a potential upside of 34.61%. Given Premium Brands' stronger consensus rating and higher possible upside, analysts clearly believe Premium Brands is more favorable than Bausch Health Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bausch Health Companies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Premium Brands	0 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.92

Bausch Health Companies has a beta of 0.942978, suggesting that its share price is 6% less volatile than the broader market. Comparatively, Premium Brands has a beta of 0.88205, suggesting that its share price is 12% less volatile than the broader market.

In the previous week, Premium Brands had 1 more articles in the media than Bausch Health Companies. MarketBeat recorded 1 mentions for Premium Brands and 0 mentions for Bausch Health Companies. Bausch Health Companies' average media sentiment score of 0.00 equaled Premium Brands'average media sentiment score.

Company	Overall Sentiment
Bausch Health Companies	Neutral
Premium Brands	Neutral

11.0% of Bausch Health Companies shares are owned by institutional investors. Comparatively, 31.7% of Premium Brands shares are owned by institutional investors. 11.3% of Bausch Health Companies shares are owned by company insiders. Comparatively, 2.0% of Premium Brands shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Premium Brands has lower revenue, but higher earnings than Bausch Health Companies. Bausch Health Companies is trading at a lower price-to-earnings ratio than Premium Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bausch Health Companies	C$10.53B	0.25	-C$125.65M	-C$3.24	N/A
Premium Brands	C$7.88B	0.58	C$99.56M	C$0.90	97.91

Summary

Premium Brands beats Bausch Health Companies on 10 of the 15 factors compared between the two stocks.

How does Bausch Health Companies compare to Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals (TSE:AUP) and Bausch Health Companies (TSE:BHC) are both mid-cap pharmaceutical products companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, dividends, valuation, media sentiment, earnings, analyst recommendations and profitability.

11.0% of Bausch Health Companies shares are held by institutional investors. 11.3% of Bausch Health Companies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Aurinia Pharmaceuticals has a net margin of 0.00% compared to Bausch Health Companies' net margin of -13.54%. Bausch Health Companies' return on equity of 120.43% beat Aurinia Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aurinia Pharmaceuticals	N/A	N/A	N/A
Bausch Health Companies	-13.54%	120.43%	4.16%

In the previous week, Aurinia Pharmaceuticals' average media sentiment score of 0.00 equaled Bausch Health Companies'average media sentiment score.

Company	Overall Sentiment
Aurinia Pharmaceuticals	Neutral
Bausch Health Companies	Neutral

Given Aurinia Pharmaceuticals' higher possible upside, equities analysts clearly believe Aurinia Pharmaceuticals is more favorable than Bausch Health Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurinia Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Bausch Health Companies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Bausch Health Companies has higher revenue and earnings than Aurinia Pharmaceuticals. Bausch Health Companies is trading at a lower price-to-earnings ratio than Aurinia Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurinia Pharmaceuticals	C$57.59M	0.00	-C$190.03M	-C$1.48	N/A
Bausch Health Companies	C$10.53B	0.25	-C$125.65M	-C$3.24	N/A

Summary

Bausch Health Companies beats Aurinia Pharmaceuticals on 8 of the 11 factors compared between the two stocks.

How does Bausch Health Companies compare to Solaris Resources?

Solaris Resources (TSE:SLS) and Bausch Health Companies (TSE:BHC) are both mid-cap pharmaceutical products companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, earnings, dividends, analyst recommendations, valuation and profitability.

Solaris Resources has a beta of 1.721408, suggesting that its share price is 72% more volatile than the broader market. Comparatively, Bausch Health Companies has a beta of 0.942978, suggesting that its share price is 6% less volatile than the broader market.

16.5% of Solaris Resources shares are held by institutional investors. Comparatively, 11.0% of Bausch Health Companies shares are held by institutional investors. 40.6% of Solaris Resources shares are held by insiders. Comparatively, 11.3% of Bausch Health Companies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Solaris Resources has a net margin of 0.00% compared to Bausch Health Companies' net margin of -13.54%. Bausch Health Companies' return on equity of 120.43% beat Solaris Resources' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Solaris Resources	N/A	60.97%	-51.67%
Bausch Health Companies	-13.54%	120.43%	4.16%

Solaris Resources has higher earnings, but lower revenue than Bausch Health Companies. Solaris Resources is trading at a lower price-to-earnings ratio than Bausch Health Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Solaris Resources	N/A	N/A	-C$46.49M	-C$0.19	N/A
Bausch Health Companies	C$10.53B	0.25	-C$125.65M	-C$3.24	N/A

Solaris Resources currently has a consensus price target of C$19.50, suggesting a potential upside of 48.85%. Given Solaris Resources' stronger consensus rating and higher probable upside, equities analysts plainly believe Solaris Resources is more favorable than Bausch Health Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solaris Resources	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Bausch Health Companies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Solaris Resources' average media sentiment score of 0.00 equaled Bausch Health Companies'average media sentiment score.

Company	Overall Sentiment
Solaris Resources	Neutral
Bausch Health Companies	Neutral

Summary

Solaris Resources beats Bausch Health Companies on 9 of the 13 factors compared between the two stocks.

How does Bausch Health Companies compare to Cara Operations?

Cara Operations (TSE:CARA) and Bausch Health Companies (TSE:BHC) are both pharmaceutical products companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, media sentiment, analyst recommendations, risk, dividends and valuation.

In the previous week, Cara Operations' average media sentiment score of 0.00 equaled Bausch Health Companies'average media sentiment score.

Company	Overall Sentiment
Cara Operations	Neutral
Bausch Health Companies	Neutral

Cara Operations has higher earnings, but lower revenue than Bausch Health Companies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cara Operations	N/A	N/A	N/A	N/A	N/A
Bausch Health Companies	C$10.53B	0.25	-C$125.65M	-C$3.24	N/A

11.0% of Bausch Health Companies shares are held by institutional investors. 11.3% of Bausch Health Companies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Given Cara Operations' higher probable upside, equities analysts plainly believe Cara Operations is more favorable than Bausch Health Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cara Operations	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Bausch Health Companies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Cara Operations has a net margin of 0.00% compared to Bausch Health Companies' net margin of -13.54%. Bausch Health Companies' return on equity of 120.43% beat Cara Operations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cara Operations	N/A	N/A	N/A
Bausch Health Companies	-13.54%	120.43%	4.16%

Summary

Bausch Health Companies beats Cara Operations on 6 of the 8 factors compared between the two stocks.

Get Bausch Health Companies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BHC vs. The Competition

Export

Metric	Bausch Health Companies	Drug Manufacturers Industry	Medical Sector	TSE Exchange
Market Cap	C$2.65B	C$2.39B	C$6.53B	C$12.19B
Dividend Yield	0.76%	2.94%	2.67%	6.19%
P/E Ratio	-2.19	5.01	23.99	36.94
Price / Sales	0.25	1,641.46	511.38	10.45
Price / Cash	7.76	10.18	27.48	82.29
Price / Book	-2.43	10.44	10.65	4.47
Net Income	-C$125.65M	C$20.27B	C$3.57B	C$299.09M
7 Day Performance	-0.98%	-0.85%	0.58%	0.65%
1 Month Performance	-5.09%	6.93%	1.54%	-0.08%
1 Year Performance	-12.68%	15.90%	25.40%	41.90%

Bausch Health Companies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BHC Bausch Health Companies	0.3508 of 5 stars	C$7.09 flat	N/A	-12.7%	C$2.65B	C$10.53B	N/A	19,900
APHA Aphria	N/A	N/A	N/A	N/A	C$5.24B	C$611.06M	N/A	1,200
PBH Premium Brands	3.2926 of 5 stars	C$86.65 +0.6%	C$118.62 +36.9%	+10.6%	C$4.50B	C$7.88B	96.28	540
AUP Aurinia Pharmaceuticals	N/A	N/A	N/A	N/A	C$2.15B	C$57.59M	N/A	300	High Trading Volume
SLS Solaris Resources	1.477 of 5 stars	C$11.69 -0.6%	C$19.50 +66.8%	+108.6%	C$1.95B	N/A	N/A	10	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (TSE:BHC) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bausch Health Companies (BHC) Competitors

BHC vs. APHA, PBH, AUP, SLS, and CARA

How does Bausch Health Companies compare to Aphria?

Summary

How does Bausch Health Companies compare to Premium Brands?

Summary

How does Bausch Health Companies compare to Aurinia Pharmaceuticals?

Summary

How does Bausch Health Companies compare to Solaris Resources?

Summary

How does Bausch Health Companies compare to Cara Operations?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BHC vs. The Competition

Bausch Health Companies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Bausch Health Companies (BHC) Competitors

BHC vs. APHA, PBH, AUP, SLS, and CARA

How does Bausch Health Companies compare to Aphria?

Does the media refer more to BHC or APHA?

Which has higher valuation & earnings, BHC or APHA?

Is BHC or APHA more profitable?

Do analysts rate BHC or APHA?

Do institutionals and insiders have more ownership in BHC or APHA?

Summary

How does Bausch Health Companies compare to Premium Brands?

Is BHC or PBH more profitable?

Do analysts prefer BHC or PBH?

Which has more risk and volatility, BHC or PBH?

Does the media prefer BHC or PBH?

Do institutionals & insiders believe in BHC or PBH?

Which has stronger valuation and earnings, BHC or PBH?

Summary

How does Bausch Health Companies compare to Aurinia Pharmaceuticals?

Do institutionals and insiders have more ownership in AUP or BHC?

Is AUP or BHC more profitable?

Does the media favor AUP or BHC?

Do analysts prefer AUP or BHC?

Which has higher valuation and earnings, AUP or BHC?

Summary

How does Bausch Health Companies compare to Solaris Resources?

Which has more volatility & risk, SLS or BHC?

Do institutionals & insiders have more ownership in SLS or BHC?

Is SLS or BHC more profitable?

Which has preferable earnings & valuation, SLS or BHC?

Do analysts prefer SLS or BHC?

Does the media favor SLS or BHC?

Summary

How does Bausch Health Companies compare to Cara Operations?

Does the media prefer CARA or BHC?

Which has preferable earnings and valuation, CARA or BHC?

Do institutionals and insiders have more ownership in CARA or BHC?

Do analysts recommend CARA or BHC?

Is CARA or BHC more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BHC vs. The Competition

Bausch Health Companies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools